Quarterly Result15 May 2025, 01:19 am
Sanofi India Declares 4% Growth in Net Sales & 27% Growth in Operating Profits in Q1-2025
AI Summary
Sanofi India Limited has announced its financial results for the quarter ended on March 31st, 2025. The company has reported a 4% growth in net sales on a comparable basis of continuing business and a 27% increase in operating profits compared to Q1-2024. The successful launch of Soliqua®, a best-in-class diabetes drug, has contributed to this growth. The company is focusing on lowering expenses and improving operating efficiencies.
Key Highlights
- 4% growth in net sales on a comparable basis of continuing business
- 27% increase in operating profits compared to Q1-2024
- Successful launch of Soliqua®, a best-in-class diabetes drug
- Focus on lowering expenses and improving operating efficiencies